News from novelos therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 16, 2013, 08:30 ET

Novelos Therapeutics Provides Product Pipeline Update

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer,...

Feb 21, 2013, 08:30 ET

Novelos Therapeutics Closes $5.5 Million Public Offering

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Feb 13, 2013, 08:30 ET

Novelos Therapeutics Prices $5.5 Million Public Offering

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Feb 04, 2013, 08:30 ET

Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Jan 31, 2013, 08:30 ET

Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Nov 27, 2012, 08:30 ET

Novelos Therapeutics To Present At The Benchmark 2012 Micro Cap Discovery Investor Conference On November 29

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Nov 05, 2012, 08:30 ET

Novelos Therapeutics Closes $2 Million Private Placement

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Oct 25, 2012, 08:30 ET

Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Oct 03, 2012, 08:30 ET

Novelos Therapeutics and Academic Collaborators Present Diapeutic Technology Platform at Imaging in 2020 Conference

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer,...

Oct 02, 2012, 08:30 ET

Novelos Therapeutics to Present at 11th Annual Bio Investor Forum on October 10

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Sep 11, 2012, 08:30 ET

Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Sep 07, 2012, 08:30 ET

Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Sep 04, 2012, 08:30 ET

Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Aug 28, 2012, 08:30 ET

Novelos Therapeutics Developing CLR1502 (GLOW2) Cancer-Targeted Optical Imaging Agent For Intraoperative Tumor Margin Illumination

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Jun 27, 2012, 08:30 ET

Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Jun 19, 2012, 08:30 ET

Novelos Therapeutics Announces Positive Initial Imaging Results In Brain Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent At UW Carbone Cancer Center

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Jun 14, 2012, 08:30 ET

Novelos Therapeutics Closes $5.4 Million Public Offering

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer,...

Jun 08, 2012, 08:30 ET

Novelos Therapeutics Prices $5.4 Million Public Offering

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

May 15, 2012, 08:30 ET

Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Apr 24, 2012, 08:30 ET

Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge